// App-Quantinova.ai

: The clinical development history of gantenerumab, a subcutaneous anti-Aβ monoclonal antibody for early Alzheimer’s disease: Building on lessons from the past and paving a path for the future

Researchers

Presenter

  • Rachelle S. Doody

Principal Investigators

  • Janice Smith

  • Nick C Fox

  • Sandra E. Black

  • Jiong Shi

Medical Centers

  • Dementia Research Centre, Department of Neurodegenerative Disease & UK Dementia Research Institute, Institute of Neurology, University College London

  • Sunnybrook Research Institute, University of Toronto

  • China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University

  • Washington University School of Medicine, St. Louis, MO

  • F. Hoffmann-La Roche Ltd., Product Development Neuroscience

  • Roche Products Ltd.

  • 4. UK Dementia Research Institute, Queen Square Institute of Neurology, University College London,

Locations

  • United Kingdom

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Gantenerumab

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

  • Open Label

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved